Key Points
- CAO Jonathan David Lanoy sold 5,000 shares on November 18 at an average price of $20.45 for a total of $102,250, reducing his stake by 9.76% to 46,233 shares (≈$945,465).
- The company reported quarterly $0.36 EPS, beating the $0.18 estimate, but revenue missed at $88.99 million versus a $119.39 million consensus, with a net margin of 3.06%.
- Shares traded around $19.82 (down ~0.2%) with a market cap of $346.7M and a 52‑week range of $11.01–$21.64; analysts have a consensus rating of “Moderate Buy” and a $22.50 target.
Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) CAO Jonathan David Lanoy sold 5,000 shares of the stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $20.45, for a total value of $102,250.00. Following the completion of the sale, the chief accounting officer owned 46,233 shares in the company, valued at approximately $945,464.85. The trade was a 9.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Nature's Sunshine Products Trading Down 0.2%
Shares of NASDAQ NATR traded down $0.05 during mid-day trading on Thursday, reaching $19.82. The company had a trading volume of 19,524 shares, compared to its average volume of 79,081. The stock has a market cap of $346.68 million, a price-to-earnings ratio of 26.78 and a beta of 1.09. Nature's Sunshine Products, Inc. has a 52 week low of $11.01 and a 52 week high of $21.64. The business's 50-day moving average is $15.98 and its 200-day moving average is $15.50.
Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.18 by $0.18. The firm had revenue of $88.99 million for the quarter, compared to analyst estimates of $119.39 million. Nature's Sunshine Products had a return on equity of 10.19% and a net margin of 3.06%. Nature's Sunshine Products has set its FY 2025 guidance at EPS.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the company. Jacobs Levy Equity Management Inc. raised its stake in shares of Nature's Sunshine Products by 49.7% in the third quarter. Jacobs Levy Equity Management Inc. now owns 109,768 shares of the company's stock worth $1,704,000 after purchasing an additional 36,450 shares during the last quarter. NewEdge Advisors LLC lifted its stake in Nature's Sunshine Products by 2,113.6% during the 3rd quarter. NewEdge Advisors LLC now owns 15,606 shares of the company's stock valued at $242,000 after acquiring an additional 14,901 shares during the period. Verition Fund Management LLC purchased a new stake in shares of Nature's Sunshine Products in the 3rd quarter valued at $210,000. Qube Research & Technologies Ltd raised its holdings in shares of Nature's Sunshine Products by 459.8% during the third quarter. Qube Research & Technologies Ltd now owns 66,454 shares of the company's stock worth $1,031,000 after purchasing an additional 54,582 shares during the last quarter. Finally, Public Employees Retirement System of Ohio lifted its position in Nature's Sunshine Products by 76.9% during the third quarter. Public Employees Retirement System of Ohio now owns 10,791 shares of the company's stock valued at $167,000 after purchasing an additional 4,692 shares during the period. 79.40% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research analysts have recently issued reports on the company. DA Davidson lifted their price target on Nature's Sunshine Products from $21.00 to $23.00 and gave the company a "buy" rating in a report on Monday, November 10th. Weiss Ratings reiterated a "hold (c)" rating on shares of Nature's Sunshine Products in a report on Wednesday, October 8th. Finally, Canaccord Genuity Group lifted their price objective on shares of Nature's Sunshine Products from $21.00 to $22.00 and gave the stock a "buy" rating in a research report on Friday, August 1st. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $22.50.
Read Our Latest Analysis on Nature's Sunshine Products
Nature's Sunshine Products Company Profile
(
Get Free Report)
Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
